Role of Carma1 in Inflammatory Lung Disease
Role of Carma1 in Inflammatory Lung Disease
批准号:
7771637
负责人:
Benjamin David Medoff
金额:
$41.17万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2012-02-28
关键词:
AddressAntigensAsthmaBackcrossingsBiochemical GeneticsBiologyCell physiologyChronic DiseaseCollectionComplexDataDevelopmentDiseaseExperimental DesignsFamilyGenerationsGenesGlucocorticoidsGoalsHealthHost DefenseImmune responseImmunosuppressive AgentsInfectionInflammationInflammatoryLungLung diseasesLymphocyteMediatingMediator of activation proteinMemoryModelingMolecularMusMutant Strains MiceMutationOutcome StudyPathogenesisPathway interactionsPharmaceutical PreparationsPhosphorylationPhosphorylation SitePhosphotransferasesPlayPneumoniaPopulationProcessProtein FingerprintsProteinsProteomicsReceptor SignalingRegulationRegulatory T-LymphocyteResolutionRoleScaffolding ProteinSerineSignal PathwaySignal TransductionStudy SectionT cell differentiationT memory cellT-Cell ActivationT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTestingTh2 CellsTransgenic MiceTransgenic Organismsairway inflammationallergic airway inflammationantigen challengebasecandidate identificationeffective therapyimmune functionin vivoin vivo Modelinsightintermolecular interactionmouse modelnew therapeutic targetnovelpromoterpublic health relevancetranscription factortransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): NF-?B is a transcription factor crucial for regulating the expression of many genes involved in inflammation, and for the development of T cell-mediated inflammatory diseases such as asthma. Recent studies have demonstrated that the CARMA1-Bcl10- MALT1 signaling pathway is essential for TCR mediated NF-?B activation. Consistent with this, we have demonstrated that CARMA1 is essential for the development of allergic airway inflammation through its role in T lymphocytes. Furthermore, we have shown that CARMA1 dependent signal transmission is regulated by sequential phosphorylation by kinases. However, the exact mechanism of CARMA1 regulation in vivo remains elusive. In four interrelated aims, we will explore the regulation of CARMA1 in T cells and determine the effect of disruption of CARMA1 expression after the establishment of Th2-type pulmonary inflammation. The experimental design emphasizes the use of in vivo models of pulmonary inflammation as well as conventional approaches based on the analysis of interacting proteins using biochemical and genetic studies. The outcome of these studies will provide insight into NF-?B signaling in health and pulmonary inflammation, and may identify novel therapeutic targets. Aim 1: To characterize the role of CARMA1 in T lymphocytes during the development of allergic airway inflammation in a murine model of asthma. Aim 2: To characterize the role of CARMA1 in regulatory T cell (Treg) development and function in a murine model of asthma. Aim 3: To determine the in vivo role of serine phosphorylation of CARMA1 in lymphocyte signaling by transgenic analysis. Aim 4: To delineate novel components of signaling pathways activated by CARMA1 in T lymphocytes. PUBLIC HEALTH RELEVANCE. Asthma remains one of the most common chronic diseases in the world. Although effective therapy is achieved by the use of glucocorticoids and immunosuppressants, these drugs suppress a broad spectrum of immune function. In this proposal we investigate a protein involved in the development of asthma in a mouse model of disease. The information obtained from our proposed studies may allow us to develop more specific therapy for this disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Trained Immunity in the Airway Mucosa Differentiates Asthma from Allergy Alone
-
批准号:10673238
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2023
-
负责人:Benjamin David Medoff
-
依托单位:
Targeting durotaxis in lung injury and fibrosis
-
批准号:10364927
-
项目类别:
-
资助金额:$55.96万
-
财政年份:2021
-
负责人:Benjamin David Medoff
-
依托单位:
Targeting durotaxis in lung injury and fibrosis
-
批准号:10532249
-
项目类别:
-
资助金额:$58.08万
-
财政年份:2021
-
负责人:Benjamin David Medoff
-
依托单位:
Targeting the ADAM10-sEphrin-B2 pathway in pulmonary fibrosis
-
批准号:10599961
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2019
-
负责人:Benjamin David Medoff
-
依托单位:
Targeting the ADAM10-sEphrin-B2 pathway in pulmonary fibrosis
-
批准号:10372067
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2019
-
负责人:Benjamin David Medoff
-
依托单位:
Role of Carma1 in Inflammatory Lung Disease
-
批准号:7591206
-
项目类别:
-
资助金额:$41.05万
-
财政年份:2008
-
负责人:Benjamin David Medoff
-
依托单位:
Role of Carma1 in Inflammatory Lung Disease
-
批准号:7466234
-
项目类别:
-
资助金额:$40.86万
-
财政年份:2008
-
负责人:Benjamin David Medoff
-
依托单位:
Chemokines in lung transplation
-
批准号:6787296
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2003
-
负责人:Benjamin David Medoff
-
依托单位:
Chemokines in lung transplation
-
批准号:7099442
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2003
-
负责人:Benjamin David Medoff
-
依托单位:
Chemokines in lung transplantation
-
批准号:7262574
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2003
-
负责人:Benjamin David Medoff
-
依托单位:
Chemokines in lung transplantation
-
批准号:6596662
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2003
-
负责人:Benjamin David Medoff
-
依托单位:
Chemokines in lung transplation
-
批准号:6929807
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2003
-
负责人:Benjamin David Medoff
-
依托单位:
Role of the Leukotriene B4 Receptors in Asthma
-
批准号:6511639
-
项目类别:
-
资助金额:$5.44万
-
财政年份:2002
-
负责人:Benjamin David Medoff
-
依托单位:
Role of the Leukotriene B4 Receptors in Asthma
-
批准号:6406122
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2002
-
负责人:Benjamin David Medoff
-
依托单位:
Role of the Leukotriene B4 Receptors in Asthma
-
批准号:6608596
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2002
-
负责人:Benjamin David Medoff
-
依托单位:
Training Grant in Lung Cell and Molecular Biology
-
批准号:7650084
-
项目类别:
-
资助金额:$39.61万
-
财政年份:1997
-
负责人:Benjamin David Medoff
-
依托单位:
Training Grant in Lung Cell and Molecular Biology
-
批准号:8100184
-
项目类别:
-
资助金额:$37.28万
-
财政年份:1997
-
负责人:Benjamin David Medoff
-
依托单位:
Training Grant in Lung Cell and Molecular Biology
-
批准号:7884613
-
项目类别:
-
资助金额:$39.92万
-
财政年份:1997
-
负责人:Benjamin David Medoff
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: